Video Experimental Relacionado
Updated: Mar 7, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
1.8K
Resistencia primaria, adaptativa y adquirida a la inmunoterapia contra el cáncer
Padmanee Sharma1, Siwen Hu-Lieskovan2, Jennifer A Wargo3
1Department of Genitourinary Medical Oncology and Immunology,The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|February 11, 2017
Resumen
La inmunoterapia contra el cáncer ofrece respuestas duraderas para los cánceres metastásicos. Comprender los mecanismos de evasión inmune es clave para superar la resistencia y mejorar los resultados de los pacientes en el tratamiento del cáncer.
Área de la Ciencia:
- En el campo de la oncología
- Inmunología
Sus antecedentes:
- La inmunoterapia contra el cáncer ha demostrado ser prometedora en el tratamiento de cánceres metastásicos en varias histologías.
- Sin embargo, la comprensión limitada de los mecanismos de resistencia dificulta una aplicación clínica más amplia.
Objetivo del estudio:
- Explorar las interacciones dinámicas entre el sistema inmunológico y las células cancerosas a lo largo de la progresión de la enfermedad.
- Identificar los mecanismos moleculares subyacentes a la resistencia a la inmunoterapia contra el cáncer.
Principales métodos:
- El estudio revisa la relación en evolución entre el cáncer y el sistema inmunológico.
- Se centra en las estrategias de evasión inmunológica empleadas por las células cancerosas.
- La elucidación de las vías de resistencia molecular es central.
Principales resultados:
- La inmunoterapia contra el cáncer puede inducir respuestas duraderas en la enfermedad metastásica.
- La evasión inmune es un factor crítico en la progresión y metástasis del cáncer.
- Comprender los mecanismos de resistencia es crucial para el desarrollo terapéutico.
Conclusiones:
- Es esencial una mejor comprensión de los mecanismos de resistencia a la inmunoterapia.
- Dirigirse a estos mecanismos puede conducir a mejores estrategias clínicas.
- Esta investigación tiene como objetivo mejorar los resultados de los pacientes en la inmunoterapia contra el cáncer.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:27Cytotoxic T Cells-mediated Immune Response
7.7K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
01:40Cell-mediated Immune Responses
85.4K
Overview
85.4K